Gestational Trophoblastic DiseaseSymptoms, Doctors, Treatments, Advances & More
Gestational Trophoblastic Disease Overview
Learn About Gestational Trophoblastic Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Michael Seckl practices practicing medicine in London, United Kingdom. Mr. Seckl is rated as an Elite expert by MediFind in the treatment of Gestational Trophoblastic Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Gestational Trophoblastic Disease, Choriocarcinoma, Hydatidiform Mole, Hysterectomy, and Orchiectomy.
Giorgia Mangili practices practicing medicine in Milan, Italy. Ms. Mangili is rated as an Elite expert by MediFind in the treatment of Gestational Trophoblastic Disease. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Gestational Trophoblastic Disease, Hydatidiform Mole, Ovarian Cancer, Oophorectomy, and Salpingo-Oophorectomy.
Alice Bergamini practices practicing medicine in Milan, Italy. Ms. Bergamini is rated as an Elite expert by MediFind in the treatment of Gestational Trophoblastic Disease. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Gestational Trophoblastic Disease, Ovarian Cancer, Endometrial Cancer, Salpingo-Oophorectomy, and Hysterectomy.
Summary: The purpose of present study is to provide clinical evidences for the appropriate management of molar pregnancy with lung nodule. The hydatidiform mole patients with lung nodule ≥1.0cm will be randomized into 2 groups: A. treated with chemotherapy immediately, B. follow up until hCG level met FIGO diagnostic criteria of GTN (B1) or hCG level declined to normal spontaneously (B2). Lung nodule \<1.0...
Summary: The purpose of this study is to evaluate the efficacy and safety of camrelizumab and apatinib as combination therapy in patients with ultra high-risk (Cohort A) and high-risk chemo-refractory or relapsed (Cohort B) gestational trophoblastic neoplasia (GTN). Eligible patients will receive camrelizumab plus apatinib plus chemotherapy. Treatment will be continued until disease progression, unacceptab...